Similar articles for PMID: 25524394

Year	Number of Results
1989	1
1990	1
1991	1
1993	2
1994	1
1995	2
1996	2
1999	2
2000	1
2001	3
2003	5
2004	3
2005	5
2006	3
2007	2
2008	3
2010	2
2011	3
2012	3
2013	2
2014	5
2015	9
2016	11
2017	3
2018	12
2019	3
2020	4
2021	4
2022	2
2024	0

1

Going back to class I: MHC and immunotherapies for childhood cancer.

Haworth KB, Leddon JL, Chen CY, Horwitz EM, Mackall CL, Cripe TP. Haworth KB, et al. Pediatr Blood Cancer. 2015 Apr;62(4):571-6. doi: 10.1002/pbc.25359. Epub 2014 Dec 18. Pediatr Blood Cancer. 2015. PMID: 25524394 Free PMC article. Review.

2

Characterization of MHC Class I and β-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic Trials.

Haworth KB, Arnold MA, Pierson CR, Leddon JL, Kurmashev DK, Swain HM, Hutzen BJ, Roberts RD, Cripe TP. Haworth KB, et al. Pediatr Blood Cancer. 2016 Apr;63(4):618-26. doi: 10.1002/pbc.25842. Epub 2015 Nov 17. Pediatr Blood Cancer. 2016. PMID: 26575538

3

HLA class I antigens in human tumors.

Garrido F, Cabrera T, Lopez-Nevot MA, Ruiz-Cabello F. Garrido F, et al. Adv Cancer Res. 1995;67:155-95. doi: 10.1016/s0065-230x(08)60713-7. Adv Cancer Res. 1995. PMID: 8571814 Review. No abstract available.

4

MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It.

Shklovskaya E, Rizos H. Shklovskaya E, et al. Int J Mol Sci. 2021 Jun 23;22(13):6741. doi: 10.3390/ijms22136741. Int J Mol Sci. 2021. PMID: 34201655 Free PMC article. Review.

5

Naked RNA vaccine controls tumors with down-regulated MHC class I expression through NK cells and perforin-dependent pathways.

Cheng WF, Hung CF, Lee CN, Su YN, Chang MC, He L, Wu TC, Chen CA, Hsieh CY. Cheng WF, et al. Eur J Immunol. 2004 Jul;34(7):1892-900. doi: 10.1002/eji.200424877. Eur J Immunol. 2004. PMID: 15214037 Free article.

6

Tumour MHC class I downregulation and immunotherapy (Review).

Bubeník J. Bubeník J. Oncol Rep. 2003 Nov-Dec;10(6):2005-8. Oncol Rep. 2003. PMID: 14534734 Review.

7

Cancer immune escape: MHC expression in primary tumours versus metastases.

Garrido F, Aptsiauri N. Garrido F, et al. Immunology. 2019 Dec;158(4):255-266. doi: 10.1111/imm.13114. Epub 2019 Oct 1. Immunology. 2019. PMID: 31509607 Free PMC article. Review.

8

Retuning of Mouse NK Cells after Interference with MHC Class I Sensing Adjusts Self-Tolerance but Preserves Anticancer Response.

Wagner AK, Wickström SL, Tallerico R, Salam S, Lakshmikanth T, Brauner H, Höglund P, Carbone E, Johansson MH, Kärre K. Wagner AK, et al. Cancer Immunol Res. 2016 Feb;4(2):113-23. doi: 10.1158/2326-6066.CIR-15-0001. Epub 2015 Nov 20. Cancer Immunol Res. 2016. PMID: 26589766

9

Coexpression of CD40L and CD70 by semiallogenic tumor cells induces anti-tumor immunity.

Cormary C, Hiver E, Mariamé B, Favre G, Tilkin-Mariamé AF. Cormary C, et al. Cancer Gene Ther. 2005 Dec;12(12):963-72. doi: 10.1038/sj.cgt.7700861. Cancer Gene Ther. 2005. PMID: 15956983

10

Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy.

Huang MA, Krishnadas DK, Lucas KG. Huang MA, et al. J Immunol Res. 2015;2015:675269. doi: 10.1155/2015/675269. Epub 2015 Oct 26. J Immunol Res. 2015. PMID: 26587548 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year